Haemonetics is trading 4.08% up at $124.32 as U.S. markets rally. - Major indexes were up more than 2% around this time. - No clear company-specific announcement explains the November 4 move. - Ahead of Haemonetics’ November 5 earnings report, analysts expect $345.15 million in revenue and $1.29 adjusted EPS. The preview is upcoming news, not reported results, and does not establish a company-specific catalyst for this morning’s gain.